Psoriasis, eczema, and other inflammatory skin disorders are chronic conditions that affect millions of people worldwide, often impacting both physical health and quality of life. Advances in immunology and dermatological research have led to a better understanding of these diseases and the development of more targeted and effective therapies.
Biologic medications, immunomodulators, precision medicine, and personalized treatment approaches have transformed the management of inflammatory skin diseases, improving symptom control and long-term patient care. Early diagnosis and comprehensive disease management remain essential for achieving optimal clinical outcomes.
This session will explore current advances in the diagnosis and treatment of psoriasis, eczema, atopic dermatitis, and other inflammatory skin disorders, highlighting novel biologic therapies, clinical guidelines, emerging research, and innovative strategies for improving patient care.